The Ontario Bioscience Innovation Organization (OBIO®) founded in 2009, is a not-for-profit, membership based organization engaged in strategy, programming, policy development and advocacy to further the commercialization of Ontario’s human health science companies positioning Ontario as a leader in the international marketplace. OBIO advances this goal through collaborative partnerships with industry, the investment community, academia, patients and government.
OBIO offers numerous ‘Interconnectivity’ related activities that bring together people in the fields of industry, academia, government and the investment community for networking and learning over meals, at workshops and events. Cross stakeholder experiences allow people to share knowledge and ideas, solve problems, and advance a shared vision of a fully-functioning ecosystem in which companies are founded, operate and grow.
OBIO’s Access to Capital initiative advances policies and programs designed to increase investment in the Ontario health sciences sector. The Capital Access Advisory Program (CAAP) provides strategic guidance to enhance the venture-readiness profiles of Ontario companies. The CAAP international advisor network includes senior members of the venture community and successful health sciences executives. OBIO’s MINT (Mentoring, Investors, Networking, Targeted Advice) program operates upstream of CAAP and benefits companies currently raising “seed” or later rounds of financing. The Health to Business Bridge (H2BB) program supports the development of business-trained talent across Ontario’s health science sector.
- Accelerators, Incubators & Financing
- Angel & Venture Capital
- Government & Non-Profits
- Industry Associations